SVB Leerink Downgrades Amneal Pharmaceuticals (AMRX) to Market Perform
Tweet
Share
E-mailGet Alerts AMRX Hot Sheet
Price: $18.42 +1.49%
Rating Summary:
6 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
6 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
SVB Leerink analyst Ami Fadia downgraded Amneal Pharmaceuticals (: AMRX) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Amneal Pharmaceuticals click here. For more ratings news on Amneal Pharmaceuticals click here.
Shares of Amneal Pharmaceuticals closed at $1.75 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Downgrades Assicurazioni Generali SpA (G:IM) (ARZGY) to Neutral
- JPMorgan Downgrades Millicom International Cellular SA (TIGO) to Neutral
- BWS Financial Downgrades Inter Parfums (IPAR) to Sell
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
